Back to Search
Start Over
Response to ibrutinib of refractory life-threatening autoimmune hemolytic anemia occurring in a relapsed chronic lymphocytic leukemia patient with 17p deletion
- Source :
- Leukemia & Lymphoma. 57:2685-2688
- Publication Year :
- 2016
- Publisher :
- Informa UK Limited, 2016.
-
Abstract
- Autoimmune hemolytic anemia (AIHA) is one of the most common disease-specific complications of chronic lymphocytic leukemia (CLL), occurring in 3–10% of patients, with a higher incidence in advance...
- Subjects :
- Cancer Research
medicine.medical_specialty
Anemia
Chronic lymphocytic leukemia
NO
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
Refractory
Hematology
Oncology
hemic and lymphatic diseases
Internal medicine
medicine
business.industry
Incidence (epidemiology)
medicine.disease
Leukemia
chemistry
030220 oncology & carcinogenesis
Ibrutinib
Immunology
Autoimmune hemolytic anemia
business
030215 immunology
Subjects
Details
- ISSN :
- 10292403 and 10428194
- Volume :
- 57
- Database :
- OpenAIRE
- Journal :
- Leukemia & Lymphoma
- Accession number :
- edsair.doi.dedup.....518421e3771557ef16f71c081c18dce0